ARIAD PHARMACEUTICALS INC Selling, General and Administrative Expense
ARIAD PHARMACEUTICALS INC reported Selling, General and Administrative Expense of $26.25 million for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2016-11-08
- ARIAD PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2016-09-30 was $26.25M, a 28.56% decline year-over-year.
- ARIAD PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2016-06-30 was $34.24M, a 29.58% decline year-over-year.
- ARIAD PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2016-03-31 was $35.98M, a 7.23% increase year-over-year.
- ARIAD PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2015-12-31 was $43.83M, a 8.56% increase year-over-year.
- ARIAD PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2015 was $162.75M, a 16.42% increase from fiscal 2014.
- ARIAD PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2014 was $139.79M, a 4.66% decline from fiscal 2013.
- ARIAD PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2013 was $146.62M, a 140.71% increase from fiscal 2012.
- ARIAD PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2012 was $60.91M, a 149.83% increase from fiscal 2011.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2016-09-30 | $26.25M 10-Q · filed 2016-11-08 | $60.49M derived: sum of 2 quarters · filed 2016-11-08 | $96.47M 10-Q · filed 2016-11-08 | $140.30M derived: sum of 4 quarters · filed 2016-11-08 |
| 2016-06-30 | $34.24M 10-Q · filed 2016-08-08 | $70.22M 10-Q · filed 2016-08-08 | $114.05M derived: sum of 3 quarters · filed 2016-08-08 | $150.80M derived: sum of 4 quarters · filed 2016-11-08 |
| 2016-03-31 | $35.98M 10-Q · filed 2016-05-10 | $79.81M derived: sum of 2 quarters · filed 2016-05-10 | $116.56M derived: sum of 3 quarters · filed 2016-11-08 | $165.18M derived: sum of 4 quarters · filed 2016-11-08 |
| 2015-12-31 | $43.83M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $80.58M derived: sum of 2 quarters · filed 2016-11-08 | $129.20M derived: sum of 3 quarters · filed 2016-11-08 | $162.75M 10-K · filed 2016-02-29 |
| 2015-09-30 | $36.74M 10-Q · filed 2016-11-08 | $85.37M derived: sum of 2 quarters · filed 2016-11-08 | $118.92M 10-Q · filed 2016-11-08 | $159.29M derived: sum of 4 quarters · filed 2016-11-08 |
| 2015-06-30 | $48.62M 10-Q · filed 2016-08-08 | $82.17M 10-Q · filed 2016-08-08 | $122.55M derived: sum of 3 quarters · filed 2016-08-08 | $156.17M derived: sum of 4 quarters · filed 2016-08-08 |
| 2015-03-31 | $33.55M 10-Q · filed 2016-05-10 | $73.93M derived: sum of 2 quarters · filed 2016-05-10 | $107.55M derived: sum of 3 quarters · filed 2016-05-10 | $141.75M derived: sum of 4 quarters · filed 2016-05-10 |
| 2014-12-31 | $40.38M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $74.00M derived: sum of 2 quarters · filed 2016-02-29 | $108.20M derived: sum of 3 quarters · filed 2016-02-29 | $139.79M 10-K · filed 2016-02-29 |
| 2014-09-30 | $33.62M 10-Q · filed 2015-11-06 | $67.82M derived: sum of 2 quarters · filed 2015-11-06 | $99.41M 10-Q · filed 2015-11-06 | $137.05M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $34.20M 10-Q · filed 2015-08-07 | $65.79M 10-Q · filed 2015-08-07 | $103.43M derived: sum of 3 quarters · filed 2016-02-29 | $140.82M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $31.59M 10-Q · filed 2015-05-08 | $69.23M derived: sum of 2 quarters · filed 2016-02-29 | $106.62M derived: sum of 3 quarters · filed 2016-02-29 | $148.72M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $37.64M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $75.03M derived: sum of 2 quarters · filed 2016-02-29 | $117.13M derived: sum of 3 quarters · filed 2016-02-29 | $146.62M 10-K · filed 2016-02-29 |
| 2013-09-30 | $37.40M 10-Q · filed 2014-11-07 | $79.50M derived: sum of 2 quarters · filed 2014-11-07 | $108.98M 10-Q · filed 2014-11-07 | $131.89M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $42.10M 10-Q · filed 2014-08-08 | $71.58M 10-Q · filed 2014-08-08 | $94.50M derived: sum of 3 quarters · filed 2015-03-02 | $108.98M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $29.48M 10-Q · filed 2014-05-09 | $52.40M derived: sum of 2 quarters · filed 2015-03-02 | $66.88M derived: sum of 3 quarters · filed 2015-03-02 | $79.10M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $22.91M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $37.40M derived: sum of 2 quarters · filed 2015-03-02 | $49.62M derived: sum of 3 quarters · filed 2015-03-02 | $60.91M 10-K · filed 2015-03-02 |
| 2012-09-30 | $14.48M 10-Q · filed 2013-11-12 | $26.71M derived: sum of 2 quarters · filed 2013-11-12 | $37.99M 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $12.22M 10-Q · filed 2013-08-09 | $23.51M 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | $11.29M 10-Q · filed 2013-05-10 | |||
| 2011-12-31 | $24.38M 10-K · filed 2014-03-03 |